FEDERATED HERMES, INC. - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 34 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 3.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2019$12,000
-55.6%
57,6130.0%0.00%
Q2 2019$27,000
+8.0%
57,6130.0%0.00%
Q1 2019$25,000
+38.9%
57,6130.0%0.00%
Q4 2018$18,000
-57.1%
57,6130.0%0.00%
Q3 2018$42,000
+68.0%
57,6130.0%0.00%
Q2 2018$25,000
-19.4%
57,6130.0%0.00%
Q1 2018$31,000
-78.9%
57,613
-74.0%
0.00%
Q4 2017$147,000
-87.0%
221,713
-88.6%
0.00%
-100.0%
Q3 2017$1,128,000
-30.8%
1,945,6820.0%0.00%
-40.0%
Q2 2017$1,630,000
-44.1%
1,945,682
-9.2%
0.01%
-37.5%
Q1 2017$2,915,000
+205.6%
2,143,4310.0%0.01%
+166.7%
Q4 2016$954,000
-87.6%
2,143,431
-67.0%
0.00%
-88.0%
Q3 2015$7,674,000
-47.2%
6,503,617
-12.8%
0.02%
-43.2%
Q2 2015$14,540,000
-9.7%
7,456,566
-17.6%
0.04%
-10.2%
Q1 2015$16,108,000
-6.3%
9,049,600
-3.2%
0.05%
-7.5%
Q4 2014$17,194,000
-25.4%
9,344,497
-1.9%
0.05%
-28.4%
Q3 2014$23,049,000
-36.5%
9,524,497
-4.2%
0.07%
-35.1%
Q2 2014$36,291,000
-22.6%
9,942,841
-2.9%
0.11%
-27.4%
Q1 2014$46,900,000
+17.9%
10,240,014
+0.1%
0.16%
+13.8%
Q4 2013$39,777,000
-15.8%
10,225,301
-1.9%
0.14%
-24.2%
Q3 2013$47,237,000
-7.3%
10,427,472
+0.5%
0.18%
-9.9%
Q2 2013$50,934,00010,373,4860.20%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Camber Capital Management LP 13,275,000$8,496,0000.41%
Broadfin Capital, LLC 2,025,268$1,296,0000.13%
Baillie Gifford 6,361,364$4,071,0000.01%
Spark Investment Management LLC 73,200$46,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,588$194,0000.00%
WEDBUSH SECURITIES INC 18,000$12,0000.00%
Financial Architects, Inc 10,000$6,0000.00%
Psagot Value Holdings Ltd. 22,050$14,0000.00%
BARCLAYS PLC 629,591$403,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 800,900$513,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders